Brazil’s CADE fines Eli Lilly for sham litigation
Drug company Eli Lilly was fined US$8.4 million on 24 June by Brazil’s competition authority CADE for filing sham lawsuits to prolong its monopoly over a cancer drug.
To read more
Subscribe to Latin Lawyer
Subscribe and start reading now
Latin Lawyer is your definitive source of news, analysis, and research from the Latin American legal community. It keeps you up to speed with the issues and trends that matter and provides the data and tools you need to operate successfully.
Subscribe now